1. Home
  2. CFG vs INSM Comparison

CFG vs INSM Comparison

Compare CFG & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Group Inc.

CFG

Citizens Financial Group Inc.

HOLD

Current Price

$61.59

Market Cap

25.7B

Sector

Finance

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$102.90

Market Cap

23.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFG
INSM
Founded
1828
1988
Country
United States
United States
Employees
17398
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.7B
23.0B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CFG
INSM
Price
$61.59
$102.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
24
Target Price
$70.17
$201.17
AVG Volume (30 Days)
3.6M
4.2M
Earning Date
04-16-2026
05-07-2026
Dividend Yield
2.86%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.17
$182.31
Revenue Next Year
$8.30
$65.19
P/E Ratio
$16.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.70
$70.57
52 Week High
$68.79
$212.75

Technical Indicators

Market Signals
Indicator
CFG
INSM
Relative Strength Index (RSI) 44.55 33.07
Support Level $58.09 $98.90
Resistance Level $62.16 $166.81
Average True Range (ATR) 1.30 4.03
MACD -0.10 0.66
Stochastic Oscillator 39.14 13.66

Price Performance

Historical Comparison
CFG
INSM

About CFG Citizens Financial Group Inc.

Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through its subsidiaries, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The group's reportable business segments are: Consumer Banking and Commercial Banking. The majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services, including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management solutions, among others, through a network of branches and ATMs.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: